Cosmos Health (COSM) Liabilities and Shareholders Equity (2011 - 2026)

Cosmos Health has disclosed Liabilities and Shareholders Equity across 16 years of filings, most recently posting $62.4 million for Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 9.05% year-over-year to $62.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $259.2 million (up 9.43% YoY) and the FY2025 annual result came in at $65.5 million, up 20.56% from the prior year.
• Liabilities and Shareholders Equity slipped to $62.4 million in Q1 2026, from $65.5 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $71.5 million in Q3 2023 and troughed at $45.6 million in Q3 2022.
• A 5-year average of $61.4 million and a median of $62.4 million in 2026 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity surged 56.78% — and 2024, when it decreased 17.73%.
• Tracing COSM's Liabilities and Shareholders Equity over 5 years: stood at $68.0 million in 2022, then slipped by 2.97% to $66.0 million in 2023, then retreated by 17.73% to $54.3 million in 2024, then gained by 20.56% to $65.5 million in 2025, then fell by 4.75% to $62.4 million in 2026.
• Business Quant data shows COSM's Liabilities and Shareholders Equity at $62.4 million in Q1 2026, $65.5 million in Q4 2025, and $69.5 million in Q3 2025.